Global Vaccine Contract Manufacturing Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027

Report ID: BMRC 1026 | Number of pages: 193 | Publish Date: Oct 2019 | Publisher: BMRC | Category: Medical Devices and Consumables
Our final report will cover impact analysis of COVID-19 outbreak
New

The detailed market intelligence report on the Global Vaccine Contract Manufacturing Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Vaccine Contract Manufacturing Market place for the forecast 2021– 2027.

Scope Of The Report:

The vaccine contract manufacturing is the process of producing the vaccination require for the treatment of various infectious diseases on the contract basis due to the huge requirement on early basis. According to the WHO, the global vaccination rate is rapidly increasing from 76% in 2013 and able to reach upto 90% with surge in immunization rate with the help of vaccines to demonstrate the high clinical demand for vaccinations.  In addition to this rise in usage for vaccines, the pharmaceutical and biopharmaceutical companies have introduced the contract based manufacturing in order to meet the global substantial demand so as to reduce the high costs of development and complex production protocols. It has become even more difficult for stakeholders to set up in-house expertise for large-scale manufacturing of vaccines. Due to this, the vaccine developers have started to outsource their manufacturing operations to contract manufacturing organizations (CMOs). Particularly, small and mid-sized players in this sector have intended to outsource a substantial proportion of clinical development and commercial-scale manufacturing processes to contract service providers. In addition to this, even huge pharmacy players are gradually entering into long-term business relationships with CMOs in order to optimize resource utilization and manage costs.

Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Vaccine Contract Manufacturing Market.

Vaccine Contract Manufacturing Market Key Players:

Antigenics Inc.
Artelis
AstraZeneca
ATM Life Sciences
ATMI
AVEO Pharmaceuticals
Bacteriological Institute of the Anhaltian Administrative Areas
Batavia Bioservices
Baxter
Baxter BioPharma Solutions
Bayer
Beijing Tiantan Biological Productions
Ben Venue Laboratories
Accugenix
Aeras Global
AfriVax
Amgen
AmProtein

Key Benefits for Vaccine Contract Manufacturing Market Reports

Global market report covers in-depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.

Vaccine Contract Manufacturing Market Segmentation:

Segmentation by Type:

Single Vaccine
Combination Vaccine

Segmentation by Application:

Application I
Application II
Application III

By Region

North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Vaccine Contract Manufacturing Market Regional Analysis –

North America is expected to dominate the vaccine contract manufacturing market with the potential rate due to presence of biopharmaceutical, and pharmaceutical companies for clinical research studies as well as rise in infectious diseases like measles, hepatitis-B, chickenpox etc. in this region. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms has more than half of the world's research & development  in pharmaceuticals spending USD 75 billion and hold the intellectual property rights on most new medicines through its advanced contract based clinical research. In addition to this according to WHO in 2018, Americas 12 countries were reported 16818 confirmed measles cases with a regional incidence rate of 16.8 per million populations, the highest rate recorded during this period.

Europe is the second-largest region for dominating the growth of vaccine contract manufacturing due to rise of infectious diseases like hepatitis-B, Corona virus, and many other due to unhealthy diet and sedative lifestyle.

The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of infectious diseases such as malaria, hepatitis-B, Corona virus etc. and rapid adoption of vaccination to prevent these diseases. According to recent data by WHO in 2018, the African region 40 countries in the have introduced pneumococcal conjugate vaccine, and the rotavirus vaccine was introduced through campaign mode for routine immunization whereas with the technical support from AFRO 42.65 million persons have been vaccinated through reactive mass vaccination campaigns which rises the outsourcing of such vaccination in these region.

This comprehensive report will provide:

Enhance your strategic decision making
Assist with your research, presentations and business plans
Show which emerging market opportunities to focus on
Increase your industry knowledge
Keep you up-to-date with crucial market developments
Allow you to develop informed growth strategies
Build your technical insight
Illustrate trends to exploit
Strengthen your analysis of competitors
Provide risk analysis, helping you avoid the pitfalls other companies could make
Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2019?
How will each segment grow over the forecast period and how much revenue will these segment account for in 2027?
Which region has more opportunities?

Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Vaccine Contract Manufacturing Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Vaccine Contract Manufacturing Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Vaccine Contract Manufacturing Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Vaccine Contract Manufacturing Market Overview: Quantitative Analysis
3.1. Global Vaccine Contract Manufacturing Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2016- 2027
3.2. Global Vaccine Contract Manufacturing Market Revenue Market Share (%), 2016- 2027
3.3. Global Vaccine Contract Manufacturing Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2016- 2027
3.4. Global Vaccine Contract Manufacturing Market Sales Market Share (%), 2016- 2027
4. Chapter – Global Vaccine Contract Manufacturing Market Analysis: Segmentation By Type
5. Chapter – Global Vaccine Contract Manufacturing Market Analysis: Segmentation By Application
6. Chapter - Global Vaccine Contract Manufacturing Market Analysis: By Manufacturer 
6.1. Global Vaccine Contract Manufacturing Market Revenue (USD Million), by Manufacturer, 2016 - 2027
6.2. Global Vaccine Contract Manufacturing Market Share (%), by Manufacturer, 2018
6.3. Global Vaccine Contract Manufacturing Market Sales (Number of Units), by Manufacturer, 2016 - 2027
6.4. Global Vaccine Contract Manufacturing Market Share (%), by Manufacturer, 2018
6.5. Global Vaccine Contract Manufacturing Market Price (USD/Unit), by Manufacturer, 2016 - 2027
6.6. Global Vaccine Contract Manufacturing Market Revenue Growth Rate (%), by Manufacturer, 2016 – 2027
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter –Vaccine Contract Manufacturing Market: Regional Analysis
7.1. North America
7.1.1. North America Vaccine Contract Manufacturing Market Revenue (USD Million) and Growth Rate (%), 2016 – 2027.
7.1.2. North America Vaccine Contract Manufacturing Market Revenue (USD Million) By Country, 2016 – 2027.
7.1.3. North America Vaccine Contract Manufacturing Revenue Market Share (%) By Country, 2016 – 2027.
7.1.4. North America Vaccine Contract Manufacturing Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2016 – 2027.
7.1.5. North America Vaccine Contract Manufacturing Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2016 – 2027.
7.1.6. North America Vaccine Contract Manufacturing Market Sales (Number of Units) and Growth Rate (%), 2016 – 2027.
7.1.7. North America Vaccine Contract Manufacturing Market Sales (Number of Units) By Country, 2016 – 2027.
7.1.8. North America Vaccine Contract Manufacturing Sales Market Share (%) By Country, 2016 – 2027.
7.1.9. North America Vaccine Contract Manufacturing Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2016 – 2027.
7.1.10. North America Vaccine Contract Manufacturing Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2016 – 2027.
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.